Kinaxis (TSE:KXS) Price Target Cut to C$200.00 by Analysts at Stifel Nicolaus

Key Points

• Stifel Nicolaus cut its price target for Kinaxis from C$245 to C$200 but maintained a "buy" rating, with the new target implying about a 43.31% upside from the stock's previous close.
• Several other brokerages (Scotiabank, RBC, Canaccord, TD, CIBC) have also trimmed targets toward C$200, leaving a consensus rating of Moderate Buy and a consensus target of C$200.11.
• Shares traded at C$139.56 on Wednesday—well below analyst targets—with a market cap of C$3.86 billion, a P/E of 56.96, and last quarter EPS of C$0.93 on C$189.95 million in revenue.

Kinaxis (TSE:KXS - Get Free Report) had its price target reduced by equities research analysts at Stifel Nicolaus from C$245.00 to C$200.00 in a research note issued to investors on Wednesday,BayStreet.CA reports. The brokerage presently has a "buy" rating on the stock. Stifel Nicolaus' price target indicates a potential upside of 43.31% from the stock's previous close.

Other equities research analysts have also recently issued research reports about the stock. Scotiabank decreased their target price on shares of Kinaxis from C$240.00 to C$200.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 4th. Royal Bank Of Canada decreased their target price on shares of Kinaxis from C$235.00 to C$200.00 and set an "outperform" rating on the stock in a research note on Monday, January 26th. Canadian Imperial Bank of Commerce decreased their target price on shares of Kinaxis from C$203.00 to C$171.00 in a research note on Friday, April 17th. Canaccord Genuity Group decreased their target price on shares of Kinaxis from C$225.00 to C$200.00 in a research note on Friday, March 6th. Finally, TD Securities decreased their target price on shares of Kinaxis from C$229.00 to C$200.00 and set a "buy" rating on the stock in a research note on Friday, March 6th. Six research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, Kinaxis currently has a consensus rating of "Moderate Buy" and a consensus target price of C$200.11.

Kinaxis Stock Performance

Shares of TSE:KXS traded down C$3.08 during trading on Wednesday, hitting C$139.56. The company's stock had a trading volume of 26,855 shares, compared to its average volume of 137,843. The company has a 50-day moving average of C$137.77 and a 200-day moving average of C$154.48. Kinaxis has a 12 month low of C$117.22 and a 12 month high of C$212.45. The company has a debt-to-equity ratio of 11.39, a current ratio of 1.97 and a quick ratio of 2.29. The firm has a market cap of C$3.86 billion, a price-to-earnings ratio of 56.96, a P/E/G ratio of 3.60 and a beta of 0.68.

Kinaxis (TSE:KXS - Get Free Report) last issued its quarterly earnings data on Wednesday, March 4th. The company reported C$0.93 earnings per share for the quarter. Kinaxis had a net margin of 12.90% and a return on equity of 16.46%. The firm had revenue of C$189.95 million for the quarter. On average, sell-side analysts expect that Kinaxis will post 4.2526231 earnings per share for the current year.

Kinaxis Company Profile

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation. Kinaxis's S&OP solution capabilities include supply and demand planning, capacity and inventory planning, and inventory management. The firm has operations in North America, Europe, and Asia-Pacific regions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.